Literature DB >> 21316895

Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.

A Szabados-Nacsa1, P Sipos, T Martinek, I Mándity, G Blazsó, Á Balogh, P Szabó-Révész, Z Aigner.   

Abstract

A tricyclic, piperidine derivative of antihistamines, loratadine, which belongs in class II of the Biopharmaceutical Classification System, was investigated. It is an ionizable drug, whose solubility depends on the gastrointestinal pH, and the bioavailability is therefore very variable. Inclusion complexes were prepared by kneading method, containing loratadine (LOR) and dimethyl-β-cyclodextrin (DIMEB) in two different molar ratios in an attempt to achieve better dissolution and therefore the better bioavailability of loratadine. The formation and physicochemical properties of the inclusion complexes were investigated by means of dissolution tests, pH-dependent solubility studies, electrospray ionization mass spectrometry and diffusion-ordered 1H NMR spectroscopy. The in vivo efficiency of the complexes was examined in rat animal experiments to confirm the better in vitro dissolution. The instrumental examinations proved the presence of total complexes in 1:1 ratio in both compositions. However, the in vitro pH-dependent solubility results, the in vivo blood levels and the greater pharmacological effect prove that excess DIMEB is needed to achieve the pH-independent and complete solubility of LOR, and therefore better and more consistent bioavailability.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316895     DOI: 10.1016/j.jpba.2011.01.024

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.

Authors:  Dandan Yang; Ruirui Li; Fang Zhang; Li Qin; Feifei Peng; Shanshan Jiang; Huiyang He; Xiumei Lu; Peng Zhang
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.

Authors:  Mazen El-Hammadi; Nisrine Awad
Journal:  AAPS PharmSciTech       Date:  2011-11-19       Impact factor: 3.246

3.  Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers.

Authors:  Mohammed H Elkomy; Shahira F El Menshawe; Heba A Abou-Taleb; Marwa H Elkarmalawy
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.